• Product NameDaclatasvir dihydrochloride
• Brief DescriptionInhibitors
• Purification99.84%
• Biological ActivityBMS-790052 is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture.
• Target NameHCV Protease inhibitor
• CAS No. 1009119-65-6
• Calculated MW 811.8
• Formulation C40H52Cl2N8O6
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC.Cl.Cl
  Pathways:Microbiology&virology; Proteases/Proteasome
  Receptor:HCV NS5A
  Boling pt:
  Melting pt:
  Solubility:DMSO: 56 mg/mL
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Fridell RA et al. Antimicrob Agents ChemOthers. 2010 Sep;54(9):3641-50.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting